Key points from article :
The Saudi royal family has started a not-for-profit organization called the Hevolution Foundation that plans to spend up to $1 billion a year.
The fund is managed by Mehmood Khan said “Our primary goal is to extend the period of healthy lifespan”.
Supporting basic research on the biology of aging and finding ways to extend the number of years people live in good health, a concept known as “health span.”
The fund will be able to take financial stakes in biotech companies.
May be looking at funding a $100 million X Prize for age reversal technology.
Nir Barzilai told an audience this April that Hevolution had agreed to fund one-third of the cost of the TAME trial.
TAME trial will investigate whether taking metformin can delay the onset of a range of age-related diseases.
Saudi Arabia has a relatively young population, but it is experiencing increasing rates of obesity and diabetes.
US research organizations will have to weigh whether they should take Hevolution’s money.
